会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • TREATMENT OF OBESITY
    • 治疗肥胖
    • US20140140949A1
    • 2014-05-22
    • US13968977
    • 2013-08-16
    • Christian-Albrechts-Universität Zu KielBaker Medical Research Institute
    • Mark Anthony FebbraioStefan Rose-John
    • C07K14/54C07K14/48
    • C07K14/5412A61K38/00C07K14/475C07K14/48C07K2319/00
    • The present invention relates generally to a method of increasing lipid oxidation in a mammal and to agents useful for same. More particularly, the present invention relates to a method of increasing lipid oxidation in a mammal by administering a ligand which interacts with the IL-6 receptor and signals via interaction with a gp130/LIF receptor heterodimer. In a related aspect, the present invention provides a method of increasing insulin sensitivity in a mammal. The method of present invention is useful, inter alia, in the treatment and/or prophylaxis of conditions characterised by unwanted lipid accumulation (such as obesity, obesity induced-metabolic disorders, type II diabetes, dyslipidemia, glucose intolerance, insulin resistance, obstructive sleep apnea, cardiovascular disease or non-alcoholic fatty liver disease) or inadequate insulin sensitivity.
    • 本发明一般涉及增加哺乳动物中脂质氧化的方法以及可用于其的药剂。 更具体地,本发明涉及通过施用与IL-6受体相互作用的配体和通过与gp130 / LIF受体异源二聚体的相互作用信号来增加哺乳动物中的脂质氧化的方法。 在相关方面,本发明提供了增加哺乳动物胰岛素敏感性的方法。 本发明的方法尤其用于治疗和/或预防特征在于不希望的脂质积聚(如肥胖,肥胖诱导的代谢紊乱,II型糖尿病,血脂异常,葡萄糖不耐受,胰岛素抵抗,阻塞性睡眠 呼吸暂停,心血管疾病或非酒精性脂肪肝疾病)或胰岛素敏感性不足。